- Home
- CORZ vs BBIO Comparison
CORZ vs BBIO Comparison
Compare CORZ & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORZ
- BBIO
- Stock Information
- Founded
- CORZ 2017
- BBIO 2015
- Country
- CORZ United States
- BBIO United States
- Employees
- CORZ N/A
- BBIO N/A
- Industry
- CORZ
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CORZ
- BBIO Health Care
- Exchange
- CORZ NYSE
- BBIO Nasdaq
- Market Cap
- CORZ 5.0B
- BBIO 5.1B
- IPO Year
- CORZ N/A
- BBIO 2019
- Fundamental
- Price
- CORZ $14.96
- BBIO $28.53
- Analyst Decision
- CORZ Strong Buy
- BBIO Strong Buy
- Analyst Count
- CORZ 13
- BBIO 13
- Target Price
- CORZ $18.67
- BBIO $48.33
- AVG Volume (30 Days)
- CORZ 11.8M
- BBIO 2.0M
- Earning Date
- CORZ 11-06-2024
- BBIO 02-20-2025
- Dividend Yield
- CORZ N/A
- BBIO N/A
- EPS Growth
- CORZ N/A
- BBIO N/A
- EPS
- CORZ N/A
- BBIO N/A
- Revenue
- CORZ $557,676,000.00
- BBIO $217,765,000.00
- Revenue This Year
- CORZ $4.33
- BBIO $2,306.97
- Revenue Next Year
- CORZ $16.55
- BBIO N/A
- P/E Ratio
- CORZ N/A
- BBIO N/A
- Revenue Growth
- CORZ 15.77
- BBIO 2209.77
- 52 Week Low
- CORZ $2.61
- BBIO $21.62
- 52 Week High
- CORZ $18.63
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- CORZ 45.84
- BBIO 59.15
- Support Level
- CORZ $13.57
- BBIO $25.34
- Resistance Level
- CORZ $17.11
- BBIO $28.15
- Average True Range (ATR)
- CORZ 1.04
- BBIO 1.33
- MACD
- CORZ -0.30
- BBIO -0.08
- Stochastic Oscillator
- CORZ 31.53
- BBIO 68.60
About CORZ CORE SCIENTIFIC INC
Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.